FIELD: medicine, dermatology. SUBSTANCE: method involves parenteral use of preparation of α2- and γ-interferons made by genetic engineering methods. Preparations of a2- and γ-interferons made by genetic engineering methods are administrated to patients intradermally or subcutaneously or intramuscularly every day or every other day for 3-20 days. Preparations of a2- and γ-interferons are administrated simultaneously at their ratio 10:1 at a single dose from 500000 to 2500000 IU and from 50000 to 250000 IU, respectively, initially at maximal dose without side reactions. Dose is changed depending on the individual tolerance, clinical dynamics of disease and in combination with known methods of treatment (for example, antibiotics, local anesthetics). EFFECT: shortened time of treatment by 1.2-1.5 times. 2 cl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT WITH CYTOKINE PREPARATIONS | 1992 |
|
RU2063036C1 |
METHOD OF TREATMENT OF SKIN VIRAL INFECTION AND MUCOUS MEMBRANES | 1992 |
|
RU2022562C1 |
METHOD OF TREATING PATIENTS WITH INFECTIOUS DISEASES | 1999 |
|
RU2146531C1 |
METHOD OF ADMINISTRATION OF PREPARATION CONTAINING RECOMBINANT α-INTERFERON | 1999 |
|
RU2174406C2 |
METHOD FOR TREATING BASALIOMAS | 2002 |
|
RU2229306C1 |
METHOD OF DETERMINATION OF MICROBE SENSITIVITY TO ANTIBIOTIC | 1997 |
|
RU2121678C1 |
METHOD OF PREPARING PERORAL MEDICINAL FORM OF CYTOKINE (ITS VARIANTS) | 1993 |
|
RU2060729C1 |
BIOLOGICALLY ACTIVE ADDITIVE | 1998 |
|
RU2129394C1 |
METHOD FOR SANITATION OF GERM CARRIER RESPIRATORY WAY | 2003 |
|
RU2257223C2 |
BIOLOGICALLY ACTIVE FOOD ADDITION | 1998 |
|
RU2125389C1 |
Authors
Dates
1994-10-30—Published
1992-03-24—Filed